Abstract
Four β-lactone -γ- lactam proteasome inhibitors of natural origin were tested for their trypanocidal activities in vitro using culture-adapted bloodstream forms of Trypanosoma brucei. All four compounds displayed activities in the nanomolar range. The most trypanocidal compounds with 50% growth inhibition (GI 50) values of around 3nM were the bromine and iodine analogues of salinosporamide A, a potent proteasome inhibitor produced by the marine actinomycete Salinispora tropica. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential of -lactone - lactam proteasome inhibitors for rational anti-trypanosomal drug development.
| Original language | English |
|---|---|
| Pages (from-to) | 131-134 |
| Number of pages | 4 |
| Journal | Planta Medica |
| Volume | 78 |
| Issue number | 2 |
| Early online date | 27 Oct 2011 |
| DOIs | |
| Publication status | Published - 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- β-lactone-γ-lactam proteasome inhibitors
- sleeping sickness
- trypanocidals
- Trypanosoma brucei
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver